PARIS — Next year sessions on new devices for transcatheter aortic valve implantation (TAVI) need to move to the main auditorium to accommodate the crowds.There were as many interventional cardiologists standing outside the room as there were sitting inside. The discussions among presenters and panelists provided insights into the state-of-the-art of this relatively new procedure as important as the clinical findings on the new devices.